Active Ingredient: NIMODIPINE
Proprietary Name: NYMALIZE
Dosage Form; Route of Administration: SOLUTION; ORAL
Strength: 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N203340
Product Number: 001
Approval Date: May 10, 2013
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information